HAS Healthcare Advanced Synthesis
Biasca, Ticino, Switzerland
Program data pending ClinicalTrials.gov matching
Profiled
Not yet scored
✓ FDA Inspections (1)
○ Clinical Trials
○ SEC Filings
○ Press
○ EMA GMP
○ MHRA GMP
✓ HC GMP (2)
Quick Facts: HAS Healthcare Advanced Synthesis
- Signal Score
- Profiled, not yet scored. Scores are published after regulatory evidence is attached and reviewed. How scoring works
- Headquarters
- Biasca, Ticino, Switzerland
- Website
- https://www.hashealthcare.com/
- Modalities
- Small Molecule API, ADC / Bioconjugation
- Active Programs
- No ClinicalTrials.gov matches confirmed
- Data Sources
- FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
About HAS Healthcare Advanced Synthesis
HAS Healthcare Advanced Synthesis is a contract development and manufacturing organization (CDMO). Capabilities: Small Molecule API, ADC / Bioconjugation. 2 manufacturing sites registered with the U.S. FDA and Health Canada: Biasca and Barbengo/Lugano (Cerbios-Pharma, acquired in 2025). Website: https://www.hashealthcare.com/
Signal Score
Profiled, not yet scored.
Scores are published after regulatory evidence is attached and reviewed.
How scoring works
HAS Healthcare Advanced Synthesis FDA Inspection History
2025-02
NAI
VAI
OAI
| Date | Site | Type | Observations | Classification |
|---|---|---|---|---|
| 2025-02-20 |
HAS Healthcare Advanced Synthesis S.A.
Biasca
Company-level
|
Drug Quality Assurance | No | No Action Indicated (NAI) |
Source: FDA Data Dashboard · Retrieved Oct 31, 2026
Hiring Activity Beta
Built from public job postings when a company's own roles can be read. Job postings are signals, not statements by the company; each one below links to the original. How we collect this
No hiring data yet. We haven't found a public jobs feed for this company.
Source:
public careers pages
· Checked Oct 30, 2026
Frequently Asked Questions About HAS Healthcare Advanced Synthesis
How many FDA inspections does HAS Healthcare Advanced Synthesis have on record?
CDMO Signal tracks 1 FDA inspection for HAS Healthcare Advanced Synthesis, sourced from the FDA inspection database. See the full inspection history above.
Has HAS Healthcare Advanced Synthesis received an FDA warning letter?
CDMO Signal has no FDA warning letters on record for HAS Healthcare Advanced Synthesis.
Does HAS Healthcare Advanced Synthesis have a CDMO Signal Score?
Not yet. HAS Healthcare Advanced Synthesis is profiled, not yet scored. Scores are published after regulatory evidence is attached and reviewed.
Evaluating HAS Healthcare Advanced Synthesis for a manufacturing program?
Use the free AI matchmaker to compare HAS Healthcare Advanced Synthesis against other CDMOs by FDA, EMA, and clinical-trial data — no login required.
Find & compare CDMOs →
Represent this organization? Contact us to verify or update this profile.
See all CDMOs in:
Similar CDMOs
CARBOGEN AMCIS
Bubendorf, Switzerland
Small Molecule API, ADC / Bioconjugation, Sterile Fill-Finish
Olon
Rodano (Milano), Italy
Small Molecule API, Biologics, ADC / Bioconjugation
Sterling Pharma Solutions
Cramlington, United Kingdom
Small Molecule API, High-Potency APIs, Peptides, ADC / Bioconjugation, Controlled Substances, Clinical Trial Manufacturing
Veranova
United States
Small Molecule API, ADC / Bioconjugation
Cohance Lifesciences
India
Small Molecule API, ADC / Bioconjugation, Peptides & Oligos
Compare HAS Healthcare Advanced Synthesis with another CDMO
Side-by-side scoring, FDA inspection history, EMA/MHRA GMP coverage, and clinical-program footprint.